Package 72189-291-90

{"route": ["ORAL"], "spl_id": "2c2947eb-f8b1-c0f8-e063-6394a90aa6f0", "openfda": {"nui": ["N0000175589", "N0000000121"], "unii": ["A0JWA85V8F"], "rxcui": ["617310"], "spl_set_id": ["d076309f-313a-1c71-e053-2995a90a7bb7"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "manufacturer_name": ["DirectRX"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (72189-291-90)", "package_ndc": "72189-291-90", "marketing_start_date": "20211110"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "72189-291_2c2947eb-f8b1-c0f8-e063-6394a90aa6f0", "dosage_form": "TABLET", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "72189-291", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "DirectRX", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN", "strength": "20 mg/1"}], "application_number": "ANDA213853", "marketing_category": "ANDA", "marketing_start_date": "20211110", "listing_expiration_date": "20261231"}